Novo Nordisk A/S (NVO) Earnings Date, Estimates & Call Transcripts → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free NVO Stock Alerts $123.05 -0.97 (-0.78%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (Jan. 31) $0.71 Beat By $0.05 Consensus EPS (Jan. 31) $0.66 Get Novo Nordisk A/S Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Novo Nordisk A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$3.32 EPSNext Year EPS Consensus Estimate: $4.09 EPSNVO Earnings Date and InformationNovo Nordisk A/S last issued its quarterly earnings data on January 31st, 2024. The reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.66 by $0.05. The business had revenue of $9.51 billion for the quarter, compared to analysts' expectations of $9.14 billion. Novo Nordisk A/S has generated $2.90 earnings per share over the last year ($2.90 diluted earnings per share) and currently has a price-to-earnings ratio of 42.4. Earnings for Novo Nordisk A/S are expected to grow by 23.19% in the coming year, from $3.32 to $4.09 per share. Novo Nordisk A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Novo Nordisk A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024Estimated)------- 1/31/2024Q4 2023$0.66$0.71+$0.05$0.71$9.14 billion$9.51 billion11/2/2023Q3 2023$0.69$0.73+$0.04$0.73-$8.58 billion8/10/2023Q2 2023$0.3350$0.3150($0.02)$1.26$8.44 billion$7.93 billion 5/4/2023Q1 2023$0.3175$0.3175-$1.27$7.86 billion$7.69 billion2/1/2023Q4 2022$0.2025$0.2075+$0.0050$0.83$6.74 billion$6.60 billion11/2/2022Q3 2022$0.21$0.2150+$0.0050$0.86$6.09 billion$6.17 billion Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 8/3/2022Q2 2022$0.2175$0.21($0.0075)$0.84$5.86 billion$5.91 billion4/29/2022Q1 2022$0.2125$0.2350+$0.0225$0.94$5.82 billion$6.34 billion2/2/2022Q4 2021$0.1775$0.1825+$0.0050$0.73$5.63 billion$5.89 billion 11/2/2021Q3 2021$0.1950$1.3175+$1.1225$0.84$5.64 billion$5.65 billion 8/3/2021Q2 2021$0.19$1.3150+$1.1250$0.85$5.21 billion$5.35 billion Novo Nordisk A/S Earnings - Frequently Asked Questions When is Novo Nordisk A/S's earnings date? Novo Nordisk A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on NVO's earnings history. Did Novo Nordisk A/S beat their earnings estimates last quarter? In the previous quarter, Novo Nordisk A/S (NYSE:NVO) reported $0.71 earnings per share (EPS) to beat the analysts' consensus estimate of $0.66 by $0.05. Learn more on analysts' earnings estimate vs. NVO's actual earnings. How much revenue does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded annual revenue of $33.71 billion. How much profit does Novo Nordisk A/S generate each year? Novo Nordisk A/S (NYSE:NVO) has a recorded net income of $12.15 billion. NVO has generated $2.90 earnings per share over the last four quarters. What is Novo Nordisk A/S's price-to-earnings ratio? Novo Nordisk A/S (NYSE:NVO) has a trailing price-to-earnings ratio of 42.43 and a forward price-to-earnings ratio of 37.06. The price/earnings-to-growth ratio is 2.07. What is Novo Nordisk A/S's EPS forecast for next year? Novo Nordisk A/S's earnings are expected to grow from $3.32 per share to $4.09 per share in the next year, which is a 23.19% increase. More Earnings Resources from MarketBeat Related Companies: Eli Lilly and Company Earnings Results Johnson & Johnson Earnings Results Merck & Co., Inc. Earnings Results AbbVie Earnings Results AstraZeneca Earnings Results Novartis Earnings Results Abbott Laboratories Earnings Results Pfizer Earnings Results UnitedHealth Group Earnings Results Thermo Fisher Scientific Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NYSE:NVO) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
